Revolution Medicines Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +33.2% | -3.3% | +1.2% | -97.6% | +5,031.8% | +9.7% | +2.3% | +14.1% | +668.2% | -86.4% | +5.7% | – | |
| – | +86.1% | -36.3% | +22.0% | +5.1% | +8.0% | +11.8% | +14.9% | +6.8% | +9.5% | +159.1% | +76.7% | – | |
| – | +1,764.5% | -322.7% | – | – | +225.9% | -94.3% | -276.6% | – | -42.9% | -152.5% | – | – | |
| – | -8.6% | +36.7% | -24.3% | +46.7% | -65.3% | +167.3% | +128.1% | -55.0% | -42.5% | -20.1% | +148.6% | – | |
| – | -591.8% | -34.8% | – | -119.9% | +1,730.1% | -95.9% | – | -27.5% | +201.3% | +130.5% | -960.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +82,922.2% | -99.9% | +826.4% | +930.0% | +1,030.5% | -99.9% | +29,257.3% | -100.6% | – | -34.7% | +1,013.8% | – | |
| – | – | -220.7% | – | – | – | -161.3% | – | -366.4% | – | -65.6% | +654.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.